We are live on ! Find out more
CA

Cullinan Associates Portfolio holdings

AUM $1.32B
1-Year Est. Return 30.92%
This Fund
S&P 500
This Quarter Est. Return
+16.55%
1 Year Est. Return
+30.92%
3 Year Est. Return
+106.56%
5 Year Est. Return
+134.28%
10 Year Est. Return
+431.49%
AUM
$1.43B
AUM Growth
+$203M
Cap. Flow
+$23.3M
Cap. Flow %
1.63%
Top 10 Hldgs %
47.17%
Holding
186
New
16
Increased
59
Reduced
61
Closed
5

Top Buys

Rank Stock Value
1
AMGN icon
Amgen
AMGN
+$28.7M
2
ORCL icon
Oracle
ORCL
+$5.36M
3
PLD icon
Prologis
PLD
+$4.68M
4
OKTA icon
Okta
OKTA
+$3.46M
5
AEP icon
American Electric Power
AEP
+$2.54M

Top Sells

Rank Stock Value
1
SNY icon
Sanofi
SNY
+$4.32M
2
TROW icon
T. Rowe Price
TROW
+$3.96M
3
AAPL icon
Apple
AAPL
+$3.38M
4
HAS icon
Hasbro
HAS
+$2.96M
5
RTX icon
RTX Corp
RTX
+$2.86M

Sector Composition

Rank Sector Weight
1 Consumer Staples 33.24%
2 Technology 16.25%
3 Healthcare 13.1%
4 Financials 10.83%
5 Consumer Discretionary 6.82%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
MNST icon
76
Monster Beverage
MNST
$94.3B
$5.2M 0.36%
149,880
+8,720
+6% +$285K
CMI icon
77
Cummins
CMI
$87.5B
$5.07M 0.36%
29,242
+290
+1% +$46.3K
YUM icon
78
Yum! Brands
YUM
$41.8B
$5.03M 0.35%
57,898
+4,775
+9% +$408K
AFL icon
79
Aflac
AFL
$64.9B
$4.91M 0.34%
136,301
-2,650
-2% -$95.7K
LULU icon
80
lululemon athletica
LULU
$13.5B
$4.87M 0.34%
15,617
-1,821
-10% -$466K
WSM icon
81
Williams-Sonoma
WSM
$26.9B
$4.86M 0.34%
118,602
-3,600
-3% -$122K
LLY icon
82
Eli Lilly
LLY
$1.02T
$4.67M 0.33%
28,425
-2,500
-8% -$384K
SCHW
83
Charles Schwab
SCHW
$183B
$4.58M 0.32%
135,800
BNY
84
Bank of New York Mellon
BNY
$106B
$4.5M 0.32%
116,401
-2,180
-2% -$79.8K
COF icon
85
Capital One
COF
$128B
$4.38M 0.31%
69,895
MET icon
86
MetLife
MET
$61.9B
$4.36M 0.31%
119,451
-2,002
-2% -$69.7K
BRK.B icon
87
Berkshire Hathaway Class B
BRK.B
$1.1T
$4.29M 0.3%
24,054
-220
-0.9% -$40.2K
AEP icon
88
American Electric Power
AEP
$69.6B
$4.17M 0.29%
52,400
+31,100
+146% +$2.54M
OKTA icon
89
Okta
OKTA
$24.7B
$4.08M 0.29%
+20,400
New +$3.46M
CTVA icon
90
Corteva
CTVA
$52.6B
$3.56M 0.25%
132,931
+19,067
+17% +$496K
PM icon
91
Philip Morris
PM
$297B
$3.55M 0.25%
50,646
TRV icon
92
Travelers Companies
TRV
$78.1B
$3.47M 0.24%
30,447
-2,700
-8% -$285K
SWK icon
93
Stanley Black & Decker
SWK
$14.3B
$3.43M 0.24%
24,620
HD icon
94
Home Depot
HD
$331B
$3.38M 0.24%
13,484
-5,520
-29% -$1.26M
SPG icon
95
Simon Property Group
SPG
$74.4B
$3.32M 0.23%
48,555
+6,450
+15% +$405K
LRCX icon
96
Lam Research
LRCX
$367B
$3.23M 0.23%
100,000
META icon
97
Meta Platforms (Facebook)
META
$1.42T
$3.22M 0.23%
14,182
+11,382
+407% +$2.38M
CBOE icon
98
Cboe Global Markets
CBOE
$32.5B
$3.09M 0.22%
33,135
-9,245
-22% -$911K
DD icon
99
DuPont de Nemours
DD
$18.5B
$3.08M 0.22%
60,200
-2,342
-4% -$137K
MPC icon
100
Marathon Petroleum
MPC
$92.4B
$3.04M 0.21%
81,275
-8,800
-10% -$283K

Similar funds

Cullinan Associates's Q2 2020 Portfolio in Review

As of Q2 2020, Cullinan Associates held 186 positions worth $1.43B, up 17% from $1.22B the previous quarter. Its ten largest holdings account for 47% of the portfolio.

Cullinan Associates's Q2 2020 filing shows 16 new, 59 increased, 61 reduced and 5 closed positions. Its largest new stake was Okta: 20,400 shares worth $4.08M. The largest sale was Sanofi, an estimated $4.32M.

By sector, the portfolio is most concentrated in Consumer Staples at 33% of assets, down from 37% a quarter earlier, followed by Technology and Healthcare.

  • Cullinan Associates's largest Q2 2020 buy was Okta: 20,400 shares worth $4.08M.
  • Cullinan Associates added most to Amgen in Q2 2020, an estimated $28.7M increase.
  • Cullinan Associates's biggest Q2 2020 reduction was T. Rowe Price, cutting an estimated $3.96M.
  • Cullinan Associates fully exited Sanofi in Q2 2020, selling an estimated $4.32M.
  • Cullinan Associates's ten largest holdings make up 47% of its $1.43B portfolio in Q2 2020.
  • Cullinan Associates opened 16 new positions and closed 5 in Q2 2020.
  • Cullinan Associates's portfolio value rose 17% quarter-over-quarter to $1.43B.

Based on Cullinan Associates's 13F filing for Q2 2020, filed 7 Jul 2020.